Provectus Biopharmaceuticals, Inc. (PVCT)
PVCT Stock Price Chart
Explore Provectus Biopharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze PVCT price movements and trends.
PVCT Company Profile
Discover essential business fundamentals and corporate details for Provectus Biopharmaceuticals, Inc. (PVCT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Jan 1997
Employees
6.00
Website
https://www.provectusbio.comCEO
Dominic Rodrigues
Description
Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal cancer metastatic to the liver; neuroendocrine tumors metastatic to the liver; uveal melanoma metastatic to the liver; and pediatric solid tumor cancers, such as neuroblastoma, Ewing sarcoma, rhabdomyosarcoma, and osteosarcoma. The company is also developing oral formulations of current good manufacturing practice rose bengal sodium (cGMP RBS) for the treatment of adult solid tumor cancers, such as head and neck, breast, testicular, and colorectal cancers; pediatric blood cancers, including leukemia; coronavirus, an acute respiratory syndrome; multi-drug resistant bacteria, such as gram-negative bacteria; and for eye diseases, including infectious keratitis. In addition, it develops PH-10, an investigational immuno-dermatology agent for the treatment of inflammatory dermatoses, such as psoriasis and atopic dermatitis. The company was formerly known as Provectus Pharmaceuticals, Inc. and changed its name to Provectus Biopharmaceuticals, Inc. in December 2013. Provectus Biopharmaceuticals, Inc. was incorporated in 2002 and is based in Knoxville, Tennessee.
PVCT Financial Timeline
Browse a chronological timeline of Provectus Biopharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 10 Nov 2025
Earnings released on 14 Aug 2025
EPS came in at -$0.00 , while revenue for the quarter reached $57.48K .
Earnings released on 14 May 2025
EPS came in at -$0.00 , while revenue for the quarter reached $278.63K .
Earnings released on 27 Mar 2025
EPS came in at -$0.01 , while revenue for the quarter reached $14.33K .
Earnings released on 12 Nov 2024
EPS came in at -$0.00 , while revenue for the quarter reached $109.75K .
Earnings released on 13 Aug 2024
EPS came in at -$0.00 , while revenue for the quarter reached $254.99K .
Earnings released on 14 May 2024
EPS came in at -$0.00 , while revenue for the quarter reached $238.07K .
Earnings released on 28 Mar 2024
EPS came in at -$0.00 , while revenue for the quarter reached $121.11K .
Earnings released on 14 Nov 2023
EPS came in at -$0.00 , while revenue for the quarter reached $69.73K .
Earnings released on 14 Aug 2023
EPS came in at -$0.00 , while revenue for the quarter reached $161.84K .
Earnings released on 11 May 2023
EPS came in at -$0.00 , while revenue for the quarter reached $205.03K .
Earnings released on 29 Mar 2023
EPS came in at -$0.00 , while revenue for the quarter reached $164.84K .
Earnings released on 9 Nov 2022
EPS came in at -$0.00 , while revenue for the quarter reached $314.89K .
Earnings released on 11 Aug 2022
EPS came in at -$0.00 , while revenue for the quarter reached $321.71K .
Earnings released on 12 May 2022
EPS came in at -$0.00 , while revenue for the quarter reached $187.61K .
Earnings released on 29 Mar 2022
EPS came in at -$0.00 .
Earnings released on 10 Nov 2021
EPS came in at -$0.00 .
Earnings released on 12 Aug 2021
EPS came in at -$0.00 .
Earnings released on 11 May 2021
EPS came in at -$0.00 .
Earnings released on 2 Mar 2021
EPS came in at -$0.01 .
Earnings released on 12 Nov 2020
EPS came in at -$0.00 .
PVCT Stock Performance
Access detailed PVCT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.